{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T09:40:03Z","timestamp":1771062003768,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,9,19]],"date-time":"2014-09-19T00:00:00Z","timestamp":1411084800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/2046-4053-3-104","type":"journal-article","created":{"date-parts":[[2014,9,19]],"date-time":"2014-09-19T09:01:36Z","timestamp":1411117296000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["The effectiveness of gentamicin in the treatment of Neisseria gonorrhoeae: a systematic review"],"prefix":"10.1186","volume":"3","author":[{"given":"Emma","family":"Hathorn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Divya","family":"Dhasmana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lelia","family":"Duley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan DC","family":"Ross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,9,19]]},"reference":[{"issue":"23","key":"281_CR1","first-page":"8","volume":"7","author":"Health Protection England","year":"2013","unstructured":"Health Protection England: Sexually transmitted infections and chlamydia screening in England 2012. Health Prot Rep. 2013, 7 (23): 8-21.","journal-title":"Health Prot Rep"},{"key":"281_CR2","unstructured":"World Health Organization: Global incidence and prevalence of selected curable sexually transmitted infections, 2008. [\n                    http:\/\/www.who.int\/reproductivehealth\/publications\/rtis\/stisestimates\/en\/\n                    \n                  ]"},{"issue":"4","key":"281_CR3","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1136\/sti.2010.048694","volume":"87","author":"A Aghaizu","year":"2011","unstructured":"Aghaizu A, Adams EJ, Turner K, Kerry S, Hay P, Simms I, Oakeshott P: What is the cost of pelvic inflammatory disease and how much could be prevented by screening for Chlamydia trachomatis? Cost analysis of the Prevention of Pelvic Infection (POPI) trial. Sex Transm Infect. 2011, 87 (4): 312-317. 10.1136\/sti.2010.048694.","journal-title":"Sex Transm Infect"},{"issue":"5","key":"281_CR4","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/00007435-200305000-00001","volume":"30","author":"JM Yeh","year":"2003","unstructured":"Yeh JM, Hook EW, Goldie SJ: A refined estimate of the average lifetime cost of pelvic inflammatory disease. Sex Transm Dis. 2003, 30 (5): 369-378. 10.1097\/00007435-200305000-00001.","journal-title":"Sex Transm Dis"},{"issue":"4","key":"281_CR5","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1258\/ijsa.2010.010385","volume":"22","author":"KK Venkatesh","year":"2011","unstructured":"Venkatesh KK, van der Straten A, Cheng H, Cheng H, Montgomery ET, Lurie MN, Chipato T, Ramjee G, Blanchard K, Padian NS, Mayer KH, de Bruyn G: The relative contribution of viral and bacterial sexually transmitted infections on HIV acquisition in southern African women in the methods for improving reproductive health in Africa study. Int J STD AIDS. 2011, 22 (4): 218-224. 10.1258\/ijsa.2010.010385.","journal-title":"Int J STD AIDS"},{"issue":"3","key":"281_CR6","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1097\/QAD.0b013e32831ef523","volume":"23","author":"D Watson-Jones","year":"2009","unstructured":"Watson-Jones D, Baisley K, Weiss HA, Tanton C, Changalucha J, Everett D, Chirwa T, Ross D, Clayton T, Hayes R: Risk factors for HIV incidence in women participating in an HSV suppressive treatment trial in Tanzania. AIDS. 2009, 23 (3): 415-422. 10.1097\/QAD.0b013e32831ef523.","journal-title":"AIDS"},{"issue":"Suppl 1","key":"281_CR7","doi-asserted-by":"publisher","first-page":"A184","DOI":"10.1136\/sextrans-2011-050108.201","volume":"87","author":"P Pathela","year":"2011","unstructured":"Pathela P, Braunstein S, Blank S, Schillinger J: HIV incidence and time to diagnosis among men with bacterial rectal infections, New York City. Sex Transm Infect. 2011, 87 (Suppl 1): A184-","journal-title":"Sex Transm Infect"},{"issue":"9069","key":"281_CR8","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1016\/S0140-6736(97)02190-9","volume":"349","author":"MS Cohen","year":"1997","unstructured":"Cohen MS, Hoffman IF, Royce RA, Kazembe P, Dyer JR, Daly CC, Zimba D, Vernazza PL, Maida M, Fiscus SA, Eron JJ: Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1: AIDSCAP Malawi Research Group. Lancet. 1997, 349 (9069): 1868-1873. 10.1016\/S0140-6736(97)02190-9.","journal-title":"Lancet"},{"issue":"12","key":"281_CR9","doi-asserted-by":"publisher","first-page":"F85","DOI":"10.1097\/00002030-199712000-00001","volume":"11","author":"PD Ghys","year":"1997","unstructured":"Ghys PD, Fransen K, Diallo MO, Etti\u00e8gne-Traor\u00e9 V, Coulibaly IM, Yebou\u00e9 KM, Kalish ML, Maurice C, Whitaker JP, Greenberg AE, Laga M: The associations between cervicovaginal HIV shedding, sexually transmitted diseases and immunosuppression in female sex workers in Abidjan. Cote d\u2019Ivoire AIDS. 1997, 11 (12): F85-F93.","journal-title":"Cote d\u2019Ivoire AIDS"},{"issue":"1","key":"281_CR10","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1086\/513820","volume":"177","author":"WC Levine","year":"1998","unstructured":"Levine WC, Pope V, Bhoomkar A, Tambe P, Lewis JS, Zaidi AA, Farshy CE, Mitchell S, Talkington DF: Increase in endocervical CD4 lymphocytes among women with nonulcerative sexually transmitted diseases. J Infect Dis. 1998, 177 (1): 167-174. 10.1086\/513820.","journal-title":"J Infect Dis"},{"key":"281_CR11","unstructured":"HPA Guidance for gonorrhoea testing in England and Wales, 2010. [\n                    http:\/\/www.bashh.org\/BASHH\/Guidelines\/Guidelines\/BASHH\/Guidelines\/Guidelines.aspx\n                    \n                  ]"},{"issue":"7","key":"281_CR12","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1258\/ijsa.2009.009160","volume":"20","author":"C Bignell","year":"2009","unstructured":"Bignell C: European (IUSTI\/WHO) guideline on the diagnosis and treatment of gonorrhoea in adults. Int J STD AIDS. 2009, 20 (7): 453-457. 10.1258\/ijsa.2009.009160.","journal-title":"Int J STD AIDS"},{"key":"281_CR13","unstructured":"Smith DW, Tapsall JW, Lum J: Guidelines for the use and interpretation of nucleic acid detection tests for Neisseria gonorrhoea in Australia: a position paper on behalf of the Public Health Laboratory Network. [\n                    http:\/\/www.health.gov.au\/internet\/main\/publishing.nsf\/Content\/cda-cdi2904-pdf-cnt.htm\/$FILE\/cdi2904b.pdf\n                    \n                  ]"},{"key":"281_CR14","unstructured":"CDC Sexually Transmitted Diseases Guidelines, 2010: gonococcal infections. [\n                    http:\/\/www.cdc.gov\/std\/treatment\/2010\/gonococcal-infections.htm\n                    \n                  ]"},{"key":"281_CR15","unstructured":"World Health Organization: Guidelines for the management of sexually transmitted diseases. [\n                    http:\/\/www.who.int\/hiv\/pub\/sti\/en\/STIGuidelines2003.pdf\n                    \n                  ]"},{"key":"281_CR16","volume-title":"UK national guideline for the management of gonorrhoea in adults","author":"C Bignell","year":"2011","unstructured":"Bignell C, FitxGerald M: UK national guideline for the management of gonorrhoea in adults, 2011. [\n                    http:\/\/www.bashh.org\/BASHH\/Guidelines\/Guidelines\/BASHH\/Guidelines\/Guidelines.aspx\n                    \n                  ]"},{"key":"281_CR17","unstructured":"Government of South Australia, Communicable Disease Control Branch: Revision of treatment guidelines for uncomplicated gonorrhoea. [\n                    http:\/\/www.health.wa.gov.au\/diseasewatch\/vol17_issue3\/gonorrhoeae-treatment.cfm\n                    \n                  ]"},{"key":"281_CR18","unstructured":"European Centre for Disease Prevention and Control: Response plan to control and manage the threat of multi-drug resistant gonorrhoea in Europe. [\n                    http:\/\/www.ecdc.europa.eu\/en\/publications\/Publications\/1206-ECDC-MDR-gonorrhoea-response-plan.pdf\n                    \n                  ]"},{"key":"281_CR19","unstructured":"HPA GRASP 2010 Report. [\n                    http:\/\/webarchive.nationalarchives.gov.uk\/20140714084352\/http:\/\/www.hpa.org.uk\/webc\/HPAwebFile\/HPAweb_C\/1316016752917\n                    \n                  ]"},{"key":"281_CR20","unstructured":"CDC 2010 STD Surveillance Report: Gonorrhoea. [\n                    http:\/\/www.cdc.gov\/std\/stats10\/gonorrhea.htm\n                    \n                  ]"},{"issue":"7","key":"281_CR21","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.1128\/AAC.00325-11","volume":"55","author":"M Ohnishi","year":"2011","unstructured":"Ohnishi M, Golparian D, Shimuta K, Saika T, Hoshina S, Iwasaku K, Nakayama S, Kitawaki J, Unemo M: Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob Agents Chemother. 2011, 55 (7): 3538-3545. 10.1128\/AAC.00325-11.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"281_CR22","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1128\/AAC.05760-11","volume":"56","author":"M Unemo","year":"2012","unstructured":"Unemo M, Golparian D, Nicholas R, Ohnishi M, Gallay A, Sednaoui P: High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in Europe (France): novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrob Agents Chemother. 2012, 56 (3): 1273-1280. 10.1128\/AAC.05760-11.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"281_CR23","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.eimc.2011.11.010","volume":"30","author":"D Carnicer-Pont","year":"2012","unstructured":"Carnicer-Pont D, Smithson A, Fina-Homar E, Bastida MT: First cases of Neisseria gonorrhoeae resistant to ceftriaxone in Catalonia, Spain, May 2011. Enferm Infecc Microbiol Clin. 2012, 30 (4): 218-219. 10.1016\/j.eimc.2011.11.010.","journal-title":"Enferm Infecc Microbiol Clin"},{"issue":"12","key":"281_CR24","doi-asserted-by":"publisher","first-page":"3744","DOI":"10.1128\/AAC.46.12.3744-3749.2002","volume":"46","author":"S Ameyama","year":"2002","unstructured":"Ameyama S, Onodera S, Takahata M, Minami S, Maki N, Endo K, Goto H, Suzuki H, Oishi Y: Mosaic-like structure of penicillin-binding protein 2 gene (penA) in clinical isolates of Neisseria gonorrhoeae with reduced susceptibility to cefixime. Antimicrob Agents Chemother. 2002, 46 (12): 3744-3749. 10.1128\/AAC.46.12.3744-3749.2002.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"281_CR25","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1128\/AAC.49.1.137-143.2005","volume":"49","author":"M Ito","year":"2005","unstructured":"Ito M, Deguchi T, Mizutani KS, Yasuda M, Yokoi S, Ito S, Takahashi Y, Ishihara S, Kawamura Y, Ezaki T: Emergence and spread of Neisseria gonorrhoeae clinical isolates harboring mosaic-like structure of penicillin-binding protein 2 in Central Japan. Antimicrob Agents Chemother. 2005, 49 (1): 137-143. 10.1128\/AAC.49.1.137-143.2005.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"281_CR26","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ijantimicag.2005.08.021","volume":"27","author":"M Tanaka","year":"2006","unstructured":"Tanaka M, Nakayama H, Huruya K, Konomi I, Irie S, Kanayama A, Saika T, Kobayashi I: Analysis of mutations within multiple genes associated with resistance in a clinical isolate of Neisseria gonorrhoeae with reduced ceftriaxone susceptibility that shows a multidrug-resistant phenotype. Int J Antimicrob Agents. 2006, 27 (1): 20-26. 10.1016\/j.ijantimicag.2005.08.021.","journal-title":"Int J Antimicrob Agents"},{"key":"281_CR27","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1097\/OLQ.0b013e3181bf575c","volume":"37","author":"LB Brown","year":"2010","unstructured":"Brown LB, Krysiak R, Kamanga G, Mapanje C, Kanyamula H, Banda B, Mhango C, Hoffman M, Kamwendo D, Hobbs M, Hosseinipour MC, Martinson F, Cohen MS, Hoffman IF: Neisseria gonorrhoeae antimicrobial susceptibility in Lilongwe, Malawi, 2007. Sex Transm Dis. 2010, 37: 169-172. 10.1097\/OLQ.0b013e3181bf575c.","journal-title":"Sex Transm Dis"},{"issue":"6","key":"281_CR28","first-page":"384","volume":"70","author":"G Lule","year":"1994","unstructured":"Lule G, Behets FM, Hoffman IF, Dallabetta G, Hamilton HA, Moeng S, Liomba G, Cohen MS: STD\/HIV control in Malawi and the search for affordable and effective urethritis therapy: a first field evaluation. Genitourin Med. 1994, 70 (6): 384-388.","journal-title":"Genitourin Med"},{"issue":"3","key":"281_CR29","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1093\/jac\/dkq476","volume":"66","author":"SA Chisholm","year":"2011","unstructured":"Chisholm SA, Quaye N, Cole MJ, Fredlund H, Hoffmann S, Jensen JS, van de Laar MJ, Unemo M, Ison CA: An evaluation of gentamicin susceptibility of Neisseria gonorrhoeae isolates in Europe. J Antimicrob Chemother. 2011, 66 (3): 592-595. 10.1093\/jac\/dkq476.","journal-title":"J Antimicrob Chemother"},{"key":"281_CR30","unstructured":"Hathorn E, Dhasmana D, Dule L, Ross J, Harding J: The effectiveness of gentamicin in the treatment of Neisseria gonorrhoeae: a systematic review. PROSPERO: International Prospective Register of Systematic Reviews. 2012: CRD42012002490. [\n                    http:\/\/www.crd.york.ac.uk\/NIHR_PROSPERO\/\n                    \n                  ]"},{"key":"281_CR31","unstructured":"The Cochrane Collaboration: Chapter 8: Assessing risk of bias included studies. [\n                    http:\/\/handbook.cochrane.org\/\n                    \n                  ]"},{"issue":"3","key":"281_CR32","doi-asserted-by":"publisher","first-page":"301","DOI":"10.18553\/jmcp.2014.20.3.301","volume":"20","author":"NA Dreyer","year":"2014","unstructured":"Dreyer NA, Velentgas P, Westrich K, Dubois R: The GRACE checklist for rating the quality of observational studies of comparative effectiveness: a tale of hope and caution. JMCP. 2014, 20 (3): 301-308.","journal-title":"JMCP"},{"key":"281_CR33","first-page":"489","volume":"61","author":"IO Iskandar","year":"1978","unstructured":"Iskandar IO, Nahuib F, Gabry L EL: A comparative study of gentamicin, co-trimoxazole and trimethoprim-sulphametrol in acute gonococcal urethritis. J Egypt Med Assoc. 1978, 61: 489-495.","journal-title":"J Egypt Med Assoc"},{"issue":"2","key":"281_CR34","first-page":"184","volume":"26","author":"JY Yoon","year":"1988","unstructured":"Yoon JY, Kim YT, Kim JH: Treatment of uncomplicated male gonococcal urethritis: kanamycin vs. gentamicin. Korean J Dermatol. 1988, 26 (2): 184-188.","journal-title":"Korean J Dermatol"},{"issue":"2","key":"281_CR35","first-page":"177","volume":"30","author":"SS Pareek","year":"1981","unstructured":"Pareek SS, Chowdhury MNH: Comparative study between gentamicin and spectinomycin in the treatment of infections to penicillin-resistant gonococci. Curr Ther Res. 1981, 30 (2): 177-180.","journal-title":"Curr Ther Res"},{"issue":"1","key":"281_CR36","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/00007435-198501000-00011","volume":"12","author":"SK Hira","year":"1985","unstructured":"Hira SK, Attili VR, Kamanga J, Mkandawire O, Patel JS, Patel MI: Efficacy of gentamicin and kanamycin in the treatment of uncomplicated gonococcl urethritis in Zambia. Sex Transm Dis. 1985, 12 (1): 52-54. 10.1097\/00007435-198501000-00011.","journal-title":"Sex Transm Dis"},{"key":"281_CR37","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1136\/sextrans-2012-050604","volume":"88","author":"D Dowell","year":"2012","unstructured":"Dowell D, Kirkcaldy RD: Effectiveness of gentamicin for gonorrhoea treatment: systematic review and meta-analysis. Sex Transm Inf. 2012, 88: 589-594. 10.1136\/sextrans-2012-050604.","journal-title":"Sex Transm Inf"},{"key":"281_CR38","first-page":"A14","volume":"89","author":"RD Kirkcaldy","year":"2013","unstructured":"Kirkcaldy RD: Treatment of gonorrhoea in an era of emerging cephalosporin resistance and results of a randomised trial of new potential treatment options. Sex Transm Infect. 2013, 89: A14-A15. doi:10.1136\/sextrans-2013-051184.0043","journal-title":"Sex Transm Infect"}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2046-4053-3-104.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/2046-4053-3-104\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2046-4053-3-104","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2046-4053-3-104.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T20:49:22Z","timestamp":1548190162000},"score":1,"resource":{"primary":{"URL":"https:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/2046-4053-3-104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,19]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["281"],"URL":"https:\/\/doi.org\/10.1186\/2046-4053-3-104","relation":{},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,19]]},"assertion":[{"value":"10 June 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"104"}}